SG11201504805PA - Porcine parvovirus 5a, methods of use and vaccine - Google Patents

Porcine parvovirus 5a, methods of use and vaccine

Info

Publication number
SG11201504805PA
SG11201504805PA SG11201504805PA SG11201504805PA SG11201504805PA SG 11201504805P A SG11201504805P A SG 11201504805PA SG 11201504805P A SG11201504805P A SG 11201504805PA SG 11201504805P A SG11201504805P A SG 11201504805PA SG 11201504805P A SG11201504805P A SG 11201504805PA
Authority
SG
Singapore
Prior art keywords
vaccine
methods
porcine parvovirus
parvovirus
porcine
Prior art date
Application number
SG11201504805PA
Other languages
English (en)
Inventor
Arun V Iyer
Dianna M Murphy Jordan
Abby Rae Patterson
Michael B Roof
Eric Martin Vaughn
Joseph Gilbert Victoria
Callie Ann Visek
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50931160&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201504805P(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of SG11201504805PA publication Critical patent/SG11201504805PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG11201504805PA 2012-12-17 2014-01-15 Porcine parvovirus 5a, methods of use and vaccine SG11201504805PA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261738110P 2012-12-17 2012-12-17
US13/796,621 US20140170180A1 (en) 2012-12-17 2013-03-12 Porcine parvovirus 5a, methods of use and vaccine
PCT/US2013/075059 WO2014099669A1 (en) 2012-12-17 2014-01-15 Porcine parvovirus 5a, methods of use and vaccine

Publications (1)

Publication Number Publication Date
SG11201504805PA true SG11201504805PA (en) 2015-07-30

Family

ID=50931160

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201504805PA SG11201504805PA (en) 2012-12-17 2014-01-15 Porcine parvovirus 5a, methods of use and vaccine

Country Status (16)

Country Link
US (2) US20140170180A1 (es)
EP (1) EP2931741B1 (es)
AR (1) AR094725A1 (es)
AU (1) AU2014203571B2 (es)
CA (1) CA2894708A1 (es)
CL (1) CL2015001689A1 (es)
CO (1) CO7461133A2 (es)
DK (1) DK2931741T3 (es)
EA (1) EA031278B1 (es)
ES (1) ES2689515T3 (es)
MX (1) MX2015007723A (es)
PH (1) PH12015501378B1 (es)
SG (1) SG11201504805PA (es)
TW (2) TW201920662A (es)
UA (1) UA117467C2 (es)
WO (1) WO2014099669A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140170180A1 (en) 2012-12-17 2014-06-19 Boehringer Ingelheim Vetmedica, Inc. Porcine parvovirus 5a, methods of use and vaccine
US20140234354A1 (en) 2013-02-15 2014-08-21 Boehringer Ingelheim Vetmedica, Inc. Porcine parvovirus 5b, methods of use and vaccine
KR20160144383A (ko) * 2014-04-17 2016-12-16 인터벳 인터내셔널 비.브이. 돼지 파르보바이러스
WO2016210097A1 (en) * 2015-06-23 2016-12-29 The Trustees Of Columbia University In The City Of New York Novel equine parvovirus and uses thereof
DK3534939T3 (da) 2016-11-03 2023-04-24 Boehringer Ingelheim Vetmedica Gmbh Vaccine mod porcin parvovirus og porcin reproduktions- og respirationssyndromvirus og fremgangsmåder til fremstilling deraf
MX2019005137A (es) 2016-11-03 2019-06-20 Boehringer Ingelheim Vetmedica Gmbh Vacuna contra parvovirus porcino.
KR102243368B1 (ko) * 2019-04-17 2021-04-23 대한민국 돼지파보바이러스에 특이적인 단일클론항체 및 이의 용도
CN111454969B (zh) * 2019-09-02 2022-08-26 西北农林科技大学 带有双标签猪细小病毒全长感染性克隆制备方法及应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
EP0117767A1 (en) 1983-01-07 1984-09-05 Mgi Pharma, Inc. Production of parvovirus subunit vaccines
US4708871A (en) 1983-03-08 1987-11-24 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
US4567043A (en) 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
US4567042A (en) 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
FR2751227B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
WO1998011244A2 (en) * 1996-09-11 1998-03-19 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Aav4 vector and uses thereof
US20030049647A1 (en) * 2001-02-22 2003-03-13 Bassil Dahiyat Use of nucleic acid libraries to create toxicological profiles
EP2504357B1 (en) 2009-11-23 2017-08-02 Research Development Foundation Recombinant filaggrin polypeptides for cell importation
US20140170180A1 (en) 2012-12-17 2014-06-19 Boehringer Ingelheim Vetmedica, Inc. Porcine parvovirus 5a, methods of use and vaccine
US20140234354A1 (en) 2013-02-15 2014-08-21 Boehringer Ingelheim Vetmedica, Inc. Porcine parvovirus 5b, methods of use and vaccine
KR20160144383A (ko) 2014-04-17 2016-12-16 인터벳 인터내셔널 비.브이. 돼지 파르보바이러스
DK3233890T3 (en) 2014-12-19 2019-04-15 Intervet Int Bv PESTIVIRUS
US9920302B2 (en) 2015-08-31 2018-03-20 Boehringer Ingelheim Vetmedica Gmbh Pestivirus vaccines for congenital tremors
MX2019005137A (es) 2016-11-03 2019-06-20 Boehringer Ingelheim Vetmedica Gmbh Vacuna contra parvovirus porcino.

Also Published As

Publication number Publication date
US20150246113A1 (en) 2015-09-03
AR094725A1 (es) 2015-08-26
CO7461133A2 (es) 2015-11-30
TW201920662A (zh) 2019-06-01
US20140170180A1 (en) 2014-06-19
PH12015501378A1 (en) 2015-09-02
ES2689515T3 (es) 2018-11-14
TW201437369A (zh) 2014-10-01
EA031278B1 (ru) 2018-12-28
AU2014203571A1 (en) 2015-06-11
CL2015001689A1 (es) 2016-09-09
US9833507B2 (en) 2017-12-05
AU2014203571B2 (en) 2017-09-28
EP2931741B1 (en) 2018-07-25
DK2931741T3 (en) 2018-10-22
EP2931741A1 (en) 2015-10-21
TWI656213B (zh) 2019-04-11
CA2894708A1 (en) 2014-06-26
UA117467C2 (uk) 2018-08-10
EA201500643A1 (ru) 2015-12-30
PH12015501378B1 (en) 2015-09-02
WO2014099669A1 (en) 2014-06-26
MX2015007723A (es) 2015-09-23

Similar Documents

Publication Publication Date Title
HK1208683A1 (en) High-transduction-efficiency raav vectors, compositions, and methods of use raav
HK1204261A1 (en) Immunogenic wt-1 peptides and methods of use thereof wt-1
HK1203493A1 (en) Substituted azabicycles and use thereof
ZA201405858B (en) Recombinant microorganisms and methods of use thereof
EP2830692A4 (en) PATIENT INTERFACE
EP2912178A4 (en) SUPER AMPLIFIER AND METHOD FOR USE THEREOF
HK1209159A1 (en) Methods of decellularizing bone
HK1197187A1 (en) Anti-lrp5 antibodies and methods of use lrp5
SG11201504805PA (en) Porcine parvovirus 5a, methods of use and vaccine
HRP20181704T1 (hr) Kristalni oblik kidamida, metoda pripreme i uporabe istog
EP2742033A4 (en) FLAVONOID COMPOUNDS AND METHODS OF USE
GB2499286B (en) Two-part cannula dressing
HK1203198A1 (en) Substituted phenylimidazopyrazoles and use thereof
SG11201505930TA (en) Porcine parvovirus 5b, methods of use and vaccine
EP2837627A4 (en) AMIDOPYRIDINE DERIVATIVE AND USE THEREOF
EP2813495A4 (en) 2-ARYLBENZOFURAN-7-FORMAMIDE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND USE THEREOF
EP2889307A4 (en) ALPHA-CONOTOXIN PEPTIDE AND MEDICAL COMPOSITION AND THEIR OBJECTIVE
EP2807256A4 (en) MYONECTIN (CTRP15), COMPOSITION COMPRISING SAME AND METHODS OF USE
EP2800568A4 (en) COMPOSITIONS, USE METHOD AND TREATMENT METHOD THEREFOR
EP2822578A4 (en) TISSUE CONSTRUCTS AND USES THEREOF
GB201205189D0 (en) Novel medical use
HK1216891A1 (zh) 苔蘚素組合物、其製備方法和用途
GB201215502D0 (en) Medical use
HK1216727A1 (zh) 注射器裝置、注射器裝置的部件以及部件和注射器裝置的成形方法
GB2522156B (en) Hand cushion for crutches, canes and other devices